MyAverix Finance
US · Healthcare
Alto Neuroscience, Inc. (ANRO)
Biotechnology
Alto Neuroscience, Inc. (ANRO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ANRO
Alto Neuroscience, Inc. (ANRO) — FAQ
What is ANRO's P/E ratio?
The price-to-earnings (P/E) ratio for Alto Neuroscience, Inc. (ANRO) is 25.00 (data as of 2026-05-23).
Does Alto Neuroscience, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Alto Neuroscience, Inc. (ANRO). Check the MyAverix Finance app for the latest dividend data.
What sector is Alto Neuroscience, Inc. in?
Alto Neuroscience, Inc. (ANRO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ANRO listed on?
ANRO is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.